Cybin (FRA:R7E1) Operating Cash Flow per Share : €-0.16 (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Cybin Operating Cash Flow per Share?

Cybin's operating cash flow per share for the three months ended in Dec. 2023 was €-0.05. Cybin's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.16.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cybin's Operating Cash Flow per Share or its related term are showing as below:

FRA:R7E1's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Cybin Operating Cash Flow per Share Historical Data

The historical data trend for Cybin's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Operating Cash Flow per Share Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

-0.13

-0.19

-0.18

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial										-0.04	-0.04	-0.04	-0.03	-0.05

Competitive Comparison of Cybin's Operating Cash Flow per Share

For the Biotechnology subindustry, Cybin's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cybin's Price-to-Operating-Cash-Flow falls into.

Cybin Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cybin's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-32.376	/	185.429
	=	-0.17

Cybin's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-17.8	/	333.680
	=	-0.05

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.16

Cybin Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cybin's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CYBN:USA CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines